Aldeyra Therapeutics (ALDX)
NASDAQ:ALDX

Aldeyra Therapeutics (ALDX) Stock Price & Analysis

1,228 Followers

ALDX Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$2.36 - $7.99
Previous Close$6.09
Volume363.60K
Average Volume (3M)339.86K
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)$185.33M
Total Debt (Recent Filing)$15.94M
Price to Earnings (P/E)-5.5
Beta0.34
Next EarningsMar 30, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
EPS (TTM)-1.11
Shares Outstanding58,560,078
R-Squared0.07
Standard Deviation0.23
10 Day Avg. Volume372,247
30 Day Avg. Volume339,863
Price to Book (P/B)2.20
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-7.90
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside191.46% Upside
Rating ConsensusStrong Buy
Alpha0.02
Number of Analyst Covering4


Financials

Annual

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.

---

ALDX FAQ

What was Aldeyra Therapeutics’s price range in the past 12 months?
Aldeyra Therapeutics lowest stock price was $2.35 and its highest was $7.99 in the past 12 months.
    What is Aldeyra Therapeutics’s market cap?
    Currently, no data Available
    When is Aldeyra Therapeutics’s upcoming earnings report date?
    Aldeyra Therapeutics’s upcoming earnings report date is Mar 30, 2023 which is in 60 days.
      How were Aldeyra Therapeutics’s earnings last quarter?
      Aldeyra Therapeutics released its earnings results on Nov 10, 2022. The company reported -$0.25 earnings per share for the quarter, beating the consensus estimate of -$0.344 by $0.094.
        Is Aldeyra Therapeutics overvalued?
        According to Wall Street analysts Aldeyra Therapeutics’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Aldeyra Therapeutics pay dividends?
          Aldeyra Therapeutics does not currently pay dividends.
          What is Aldeyra Therapeutics’s EPS estimate?
          Aldeyra Therapeutics’s EPS estimate is -$0.31.
            How many shares outstanding does Aldeyra Therapeutics have?
            Aldeyra Therapeutics has 58,560,078 shares outstanding.
              What happened to Aldeyra Therapeutics’s price movement after its last earnings report?
              Aldeyra Therapeutics reported an EPS of -$0.25 in its last earnings report, beating expectations of -$0.344. Following the earnings report the stock price went up 6.178%.
                Which hedge fund is a major shareholder of Aldeyra Therapeutics?
                Among the largest hedge funds holding Aldeyra Therapeutics’s share is Perceptive Advisors LLC. It holds Aldeyra Therapeutics’s shares valued at 61M.

                  ---

                  Aldeyra Therapeutics Stock Smart Score

                  10
                  Outperform
                  1
                  2
                  3
                  4
                  5
                  6
                  7
                  8
                  9
                  10

                  Technicals

                  SMA
                  Positive
                  20 days / 200 days
                  Momentum
                  86.80%
                  12-Months-Change

                  Fundamentals

                  Return on Equity
                  -33.98%
                  Trailing 12-Months
                  Asset Growth
                  -23.27%
                  Trailing 12-Months
                  The Aldeyra Therapeutics stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Aldeyra Therapeutics

                  Aldeyra Therapeutics, Inc. operates as a biotechnology company. It primarily focuses on the development of new products for immune-mediated, inflammatory, orphan and other diseases that are thought to be caused in part by naturally occurring toxic chemical species known as free aldehydes. The company was founded by Thomas A. Jordan and John E. Dowling on August 13, 2004 and is headquartered in Lexington, MA.

                  ---

                  Forecast EPS vs Actual EPS


                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Kinnate Biopharma
                  Ardelyx
                  Omega Therapeutics
                  Ocugen
                  Aadi Bioscience

                  Popular Stocks

                  ---
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis